VSee Health (VSEE) Competitors $0.85 -0.02 (-2.30%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VSEE vs. BGLC, SSY, MGRX, ACON, ATIP, DHAC, NIVF, OTRK, BACK, and BTTXShould you be buying VSee Health stock or one of its competitors? The main competitors of VSee Health include BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Mangoceuticals (MGRX), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), Ontrak (OTRK), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. VSee Health vs. Its Competitors BioNexus Gene Lab SunLink Health Systems Mangoceuticals Aclarion ATI Physical Therapy Digital Health Acquisition NewGenIvf Group Ontrak IMAC Better Therapeutics BioNexus Gene Lab (NASDAQ:BGLC) and VSee Health (NASDAQ:VSEE) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk. Do insiders & institutionals hold more shares of BGLC or VSEE? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. Comparatively, 1.0% of VSee Health shares are owned by institutional investors. 0.7% of BioNexus Gene Lab shares are owned by insiders. Comparatively, 6.6% of VSee Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer BGLC or VSEE? In the previous week, BioNexus Gene Lab and BioNexus Gene Lab both had 1 articles in the media. VSee Health's average media sentiment score of 0.75 beat BioNexus Gene Lab's score of -1.15 indicating that VSee Health is being referred to more favorably in the news media. Company Overall Sentiment BioNexus Gene Lab Negative VSee Health Positive Do analysts rate BGLC or VSEE? VSee Health has a consensus target price of $5.00, suggesting a potential upside of 500.24%. Given VSee Health's stronger consensus rating and higher possible upside, analysts plainly believe VSee Health is more favorable than BioNexus Gene Lab.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00VSee Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has preferable earnings & valuation, BGLC or VSEE? BioNexus Gene Lab has higher revenue and earnings than VSee Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.51M1.07-$1.60MN/AN/AVSee HealthN/AN/A-$4.41MN/AN/A Is BGLC or VSEE more profitable? VSee Health has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -30.70%. VSee Health's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-30.70% -35.54% -29.08% VSee Health N/A N/A N/A SummaryVSee Health beats BioNexus Gene Lab on 8 of the 11 factors compared between the two stocks. Get VSee Health News Delivered to You Automatically Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VSEE vs. The Competition Export to ExcelMetricVSee HealthINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$3.00M$19.09B$29.52B$9.73BDividend YieldN/A3.79%3.10%4.09%P/E RatioN/A75.8554.5525.99Price / SalesN/A203.291,254.49122.97Price / CashN/A80.9035.3358.38Price / Book-0.2517.969.596.38Net Income-$4.41M$346.10M$805.43M$265.56M7 Day Performance6.52%2.51%1.54%1.89%1 Month Performance-40.92%-2.12%-0.15%1.23%1 Year Performance-52.40%59.42%24,107.87%21.10% VSee Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VSEEVSee Health1.5599 of 5 stars$0.83-4.3%$5.00+500.2%-50.8%$3.00MN/A0.00N/ABGLCBioNexus Gene Lab0.03 of 5 stars$5.32flatN/A+31.9%$9.58M$9.51M0.0030Negative NewsEarnings ReportSSYSunLink Health Systems2.2141 of 5 stars$1.12+16.6%N/A+37.3%$7.88M$31.09M4.661,376Gap UpMGRXMangoceuticals0.4471 of 5 stars$1.51-3.5%N/A-97.4%$7.81M$620K-0.393News CoverageShort Interest ↑ACONAclarion1.5878 of 5 stars$7.02-3.6%$11,758.50+167,400.0%-99.6%$4.07M$50K0.007Gap DownATIPATI Physical TherapyN/A$0.68flatN/A-88.6%$2.98M$741.86M-0.045,600DHACDigital Health AcquisitionN/A$0.81+3.6%N/A-55.7%$2.92MN/A0.002,021News CoverageGap UpNIVFNewGenIvf GroupN/A$1.83-4.2%N/A-99.8%$1.58M$5.43M0.00N/APositive NewsOTRKOntrak2.1817 of 5 stars$0.10-68.8%$3.00+2,900.0%-98.2%$422K$10.85M-0.01250Negative NewsBACKIMACN/A$0.08-17.3%N/A-95.5%$168K$72.05K0.00180Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/A+0.0%$5KN/A0.0040 Related Companies and Tools Related Companies BioNexus Gene Lab Competitors SunLink Health Systems Competitors Mangoceuticals Competitors Aclarion Competitors ATI Physical Therapy Competitors Digital Health Acquisition Competitors NewGenIvf Group Competitors Ontrak Competitors IMAC Competitors Better Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VSEE) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VSee Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VSee Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access